Next Article in Journal
In Vitro-In Silico Tools to Identify Biorelevant Dissolution Specifications for the Selected Poorly-Soluble Model Drugs
Previous Article in Journal
Quality-by-Design Based Characterization of Pharmaceutical Processes by Means of Numerical Simulations
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Sci. Pharm.
Volume 78
Issue 3
10.3797/scipharm.cespt.8.PPAT12
scipharm-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Scientia Pharmaceutica is published by MDPI from Volume 84 Issue 3 (2016). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Austrian Pharmaceutical Society (Österreichische Pharmazeutische Gesellschaft, ÖPhG).
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Conference Report

Application of Experimental Design for Screening Study of Dissolution Test Conditions: Levothyroxine Sodium Immediate-Release Tablets

by
I. KOCIC
*,
I. HOMSEK
and
M. DACEVIC
R&D Institute, Galenika ad, Belgrade, Serbia
*
Author to whom correspondence should be addressed.
Sci. Pharm. 2010, 78(3), 701; https://doi.org/10.3797/scipharm.cespt.8.PPAT12
Submission received: 12 July 2010 / Accepted: 12 July 2010 / Published: 12 July 2010
Versions Notes

Abstract

The aim of the study was to present an example of experimental design application to set up the dissolution test conditions for the two immediaterelease products of levothyroxine sodium (L-Na) with proven bioequivalence: the generic product A and the reference product B [1, 2]. [...]

Share and Cite

MDPI and ACS Style

KOCIC, I.; HOMSEK, I.; DACEVIC, M. Application of Experimental Design for Screening Study of Dissolution Test Conditions: Levothyroxine Sodium Immediate-Release Tablets. Sci. Pharm. 2010, 78, 701. https://doi.org/10.3797/scipharm.cespt.8.PPAT12

AMA Style

KOCIC I, HOMSEK I, DACEVIC M. Application of Experimental Design for Screening Study of Dissolution Test Conditions: Levothyroxine Sodium Immediate-Release Tablets. Scientia Pharmaceutica. 2010; 78(3):701. https://doi.org/10.3797/scipharm.cespt.8.PPAT12

Chicago/Turabian Style

KOCIC, I., I. HOMSEK, and M. DACEVIC. 2010. "Application of Experimental Design for Screening Study of Dissolution Test Conditions: Levothyroxine Sodium Immediate-Release Tablets" Scientia Pharmaceutica 78, no. 3: 701. https://doi.org/10.3797/scipharm.cespt.8.PPAT12

APA Style

KOCIC, I., HOMSEK, I., & DACEVIC, M. (2010). Application of Experimental Design for Screening Study of Dissolution Test Conditions: Levothyroxine Sodium Immediate-Release Tablets. Scientia Pharmaceutica, 78(3), 701. https://doi.org/10.3797/scipharm.cespt.8.PPAT12

Article Metrics

Back to TopTop